Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Biotech
  • General
  • News

PacBio Announces Onso, The Highly Accurate Short-Read Sequencing Platform

By Benzinga Newsdesk
October 25, 11:35 PM
The Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research MENLO PARK, Calif., Oct. 25, 2022 /PRNewswire/

PACB

Read More
3 minute read
  • Biotech
  • General
  • News

PacBio Announces Revio, A Revolutionary New Long Read Sequencing System Designed To Provide 15 Times More HiFi Data And Human Genomes At Scale For Under $1,000

By Benzinga Newsdesk
October 25, 11:34 PM
Significant Advances in SMRT Cell Design, Compute, and a New System Architecture Will Enable Revio to Dramatically Increase Throughput and Lower Cost While Leveraging the Power of HiFi for Exceptional Accuracy and Direct Methylation Detection

PACB

Read More
1 minute read
  • FDA
  • News

READ: Full Study Titled ‘Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot’

By Benzinga Newsdesk
October 25, 2:27 PM
https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1.full.pdf https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1

AZN

Read More
1 minute read
  • FDA
  • Hot
  • News

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

By Benzinga Newsdesk
October 25, 2:16 PM
-Reuters

AZN

Read More
2 minute read
  • Cannabis
  • FDA
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Canadian Company’s New Version Of Chemo-Induced Pain Treatment Is On FDA Track

By Lara Goldstein
October 25, 1:47 PM
Drug delivery company IntelGenx Corp.

ATAI

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

NexGel Highlights Positive Data From Proof-of-Concept Study For Its Diclofenac Hydrogel Pain Treatment

By Vandana Singh
October 25, 11:52 AM
NexGel Inc (NASDAQ:NXGL) announced results from its proof-of-concept study for its diclofenac hydrogel patches.  The patches are designed to treat pain…

NXGL

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks

GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day

By Vandana Singh
October 25, 11:12 AM
GSK plc (NYSE:GSK) will transfer its NY-ESO cell therapy program and the right to the PRAME cell therapy program to Adaptimmune Therapeutics…

ADAP

Read More
4 minute read
  • Biotech
  • General
  • News

ViiV Healthcare Presents Positive Proof-Of-Concept Findings For N6LS, An Investigational, Broadly Neutralising Antibody Offering A Potential New Approach For The Treatment Of HIV

By Benzinga Newsdesk
October 25, 10:09 AM
Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and

GSK

Read More
2 minute read
  • Biotech
  • General

PDC Launches Comfort Cushion Mammography Pad Yo Help Breast Health Centers Improve The Patient Experience

By Benzinga Newsdesk
October 25, 9:25 AM
PDC, a global leader of innovative identification and patient safety solutions, announced today the launch of the Comfort Cushion™ Mammography Pad for use by mammography providers, including hospitals and

BRC

Read More
2 minute read
  • Biotech
  • General

bioAffinity Technologies Announces Award Of Therapeutic Patents In China, Mexico And Australia

By Benzinga Newsdesk
October 25, 9:19 AM
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) announced the People’s Republic of China awarded a Certificate of Patent to the Company’s wholly owned subsidiary OncoSelect® for its patent

BIAF

Posts pagination

Previous 1 … 648 649 650 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service